Cullen Frost Bankers Inc. Sells 13,218 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cullen Frost Bankers Inc. reduced its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 40.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 19,434 shares of the pharmacy operator’s stock after selling 13,218 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Walgreens Boots Alliance were worth $181,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. First Financial Corp IN grew its position in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares during the last quarter. Golden State Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $26,000. Riverview Trust Co boosted its position in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,590 shares in the last quarter. Venturi Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $28,000. Finally, TD Private Client Wealth LLC boosted its position in shares of Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 3,208 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Up 7.5 %

WBA stock opened at $11.39 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $22.05. The business has a fifty day moving average price of $10.64 and a 200-day moving average price of $9.72. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock has a market capitalization of $9.84 billion, a P/E ratio of -1.11, a P/E/G ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the business earned $0.66 earnings per share. The company’s revenue was up 7.6% on a year-over-year basis. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on WBA. Royal Bank of Canada lifted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Evercore ISI lifted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Bank of America lifted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $11.54.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.